The primitive ontology strategy to quantum mechanics seeks to account for quantum phenomena by way of a distribution of matter in three-dimensional area (or four-dimensional spacetime) and a regulation of nature that describes its temporal growth. This strategy to explaining quantum phenomena is appropriate with both a Humean or powerist account of legal guidelines.
On this paper, I provide a powerist ontology during which the regulation is specified by Bohmian mechanics for a worldwide configuration of particles. Not like in different powerist ontologies, nevertheless, this regulation isn’t grounded in a structural energy that’s instantiated by the worldwide configuration. As an alternative, I mix the primitive ontology strategy with Aristotle’s doctrine of hylomorphism to create a brand new metaphysical mannequin, during which the cosmos is a hylomorphic substance with an intrinsic energy to choreograph the trajectories of the particles.
Use of a modular ontology and a semantic annotation device to explain the care pathway of sufferers with amyotrophic lateral sclerosis in a coordination community
The target of this examine was to explain the care pathway of sufferers with amyotrophic lateral sclerosis (ALS) primarily based on real-life textual knowledge from a regional coordination community, the Ile-de-France ALS community. This coordination community gives look after 92% of sufferers recognized with ALS residing in Ile-de-France. We developed a modular ontology (OntoPaRON) for the automated processing of those unstructured textual knowledge. OntoPaRON has completely different modules: the core, medical, socio-environmental, coordination, and consolidation modules.
Our strategy was distinctive in its creation of totally outlined ideas at completely different ranges of the modular ontology to handle particular matters regarding healthcare trajectories. We additionally created a semantic annotation device particular to the French language and the specificities of our corpus, the Ontology-Primarily based Semantic Annotation Module (OnBaSAM), utilizing the OntoPaRON ontology as a reference. We used these instruments to annotate the data of 928 sufferers robotically. The semantic (qualitative) annotations of the ideas have been remodeled into quantitative knowledge.
By utilizing these pipelines we have been in a position to remodel unstructured textual knowledge into structured quantitative knowledge. Primarily based on knowledge processing, semantic annotations, sociodemographic knowledge for the affected person and medical variables, we discovered that the necessity and demand for human and technical help rely on the preliminary type of the illness, the motor state, and the affected person age. The presence of exhaustion in care administration, is said to the affected person’s motor and cognitive state.

The Finish of a Classical Ontology for Quantum Mechanics?
On this paper, I argue that the Shrapnel-Costa no-go theorem undermines the final remaining viability of the view that the basic ontology of quantum mechanics is basically classical: that’s, the view that bodily actuality is underpinned by objectively actual, counterfactually particular, uniquely spatiotemporally outlined, native, dynamical entities with determinate valued properties, and the place usually ‘quantum’ behaviour emerges as a operate of our personal in-principle ignorance of such entities.
Name this view Einstein-Bell realism. One can present that the causally symmetric native hidden variable strategy to deciphering quantum concept is essentially the most pure interpretation that follows from Einstein-Bell realism, the place causal symmetry performs a big function in circumventing the nonclassical penalties of the standard no-go theorems. Nevertheless, Shrapnel and Costa argue that unique causal constructions, similar to causal symmetry, are incapable of explaining quantum behaviour as arising on account of noncontextual ontological properties of the world. That is significantly worrying for Einstein-Bell realism and classical ontology.
Within the first occasion, the apparent consequence of the theory is an easy rejection of Einstein-Bell realism. Nevertheless, greater than this, I argue that, even the place there appears to be a chance of accounting for contextual ontic variables inside a causally symmetric framework, the price of such an account undermines a key benefit of causal symmetry: that accepting causal symmetry is extra economical than rejecting a classical ontology. Both approach, it appears like we should always surrender on classical ontology.
CellO: complete and hierarchical cell kind classification of human cells with the Cell Ontology
Cell kind annotation is a elementary activity within the evaluation of single-cell RNA-sequencing knowledge. On this work, we current CellO, a machine learning-based device for annotating human RNA-seq knowledge with the Cell Ontology. CellO allows correct and standardized cell kind classification of cell clusters by contemplating the wealthy hierarchical construction of identified cell varieties. Moreover, CellO comes pre-trained on a complete knowledge set of human, wholesome, untreated main samples within the Sequence Learn Archive.
CellO’s complete coaching set allows it to expire of the field on various cell varieties and achieves aggressive and even superior efficiency when in comparison with present state-of-the-art strategies. Lastly, CellO’s linear fashions are simply interpreted, thereby enabling exploration of cell-type-specific expression signatures throughout the ontology. To this finish, we additionally current the CellO Viewer: an internet software for exploring CellO’s fashions throughout the ontology.
Ontology-Mediated Querying with Horn Description Logics
An ontology-mediated question (OMQ) consists of a database question paired with an ontology. When evaluated on a database, an OMQ returns not solely the solutions which can be already within the database, but additionally these solutions that may be obtained by way of logical reasoning utilizing guidelines from ontology. There are a lot of open questions concerning the complexities of issues associated to OMQs. Motivated by way of ontologies in observe, new reasoning issues which have by no means been thought-about within the context of ontologies turn out to be related, since they’ll enhance the usability of ontology enriched methods.
This thesis offers with varied reasoning issues that emerge from ontology-mediated querying and it investigates the computational complexity of those issues. We deal with ontologies formulated in Horn description logics, that are a preferred alternative for ontologies in observe. Specifically, the thesis offers outcomes concerning the info complexity of OMQ analysis by fully classifying complexity and rewritability questions for OMQs primarily based on an EL ontology and a conjunctive question.
Rcn3 ORF Vector (Mouse) (pORF) |
ORF055803 |
ABM |
1.0 ug DNA |
EUR 506 |
RCN3 cloning plasmid |
CSB-CL856914HU-10ug |
Cusabio |
10ug |
EUR 385 |
|
Description: A cloning plasmid for the RCN3 gene. |
RCN3 protein (His tag) |
80R-2178 |
Fitzgerald |
100 ug |
EUR 322 |
Description: Purified recombinant Human RCN3 protein (His tag) |
RCN3 Antibody, HRP conjugated |
1-CSB-PA856914LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RCN3 Antibody, FITC conjugated |
1-CSB-PA856914LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
RCN3 Antibody, Biotin conjugated |
1-CSB-PA856914LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against RCN3. Recognizes RCN3 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
RCN3 Recombinant Protein (Human) |
RP026083 |
ABM |
100 ug |
Ask for price |
RCN3 Recombinant Protein (Mouse) |
RP167405 |
ABM |
100 ug |
Ask for price |
RCN3 Recombinant Protein (Rat) |
RP223955 |
ABM |
100 ug |
Ask for price |
Mouse RCN3 shRNA Plasmid |
20-abx974231 |
Abbexa |
|
|
|
Reticulocalbin 3 (RCN3) Antibody |
abx032616-400ul |
Abbexa |
400 ul |
EUR 523 |
|
Reticulocalbin 3 (RCN3) Antibody |
abx032616-80l |
Abbexa |
80 µl |
EUR 286 |
|
Reticulocalbin 3 (RCN3) Protein |
20-abx260866 |
Abbexa |
-
EUR 3418.00
-
EUR 328.00
-
EUR 230.00
|
|
|
Human RCN3 shRNA Plasmid |
20-abx961415 |
Abbexa |
|
|
|
Polyclonal RCN3 Antibody (Center) |
AMM07556G |
Leading Biology |
0.1ml |
EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RCN3 (Center). This antibody is tested and proven to work in the following applications: |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV646664 |
ABM |
1.0 ug DNA |
EUR 514 |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV646665 |
ABM |
1.0 ug DNA |
EUR 572 |
RCN3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV646666 |
ABM |
1.0 ug DNA |
EUR 572 |
RCN3 Protein Vector (Rat) (pPB-C-His) |
PV298610 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Rat) (pPB-N-His) |
PV298611 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Rat) (pPM-C-HA) |
PV298612 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Rat) (pPM-C-His) |
PV298613 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Human) (pPB-C-His) |
PV034777 |
ABM |
500 ng |
EUR 329 |
RCN3 Protein Vector (Human) (pPB-N-His) |
PV034778 |
ABM |
500 ng |
EUR 329 |
RCN3 Protein Vector (Human) (pPM-C-HA) |
PV034779 |
ABM |
500 ng |
EUR 329 |
RCN3 Protein Vector (Human) (pPM-C-His) |
PV034780 |
ABM |
500 ng |
EUR 329 |
RCN3 Protein Vector (Mouse) (pPB-C-His) |
PV223210 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Mouse) (pPB-N-His) |
PV223211 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Mouse) (pPM-C-HA) |
PV223212 |
ABM |
500 ng |
EUR 603 |
RCN3 Protein Vector (Mouse) (pPM-C-His) |
PV223213 |
ABM |
500 ng |
EUR 603 |
Human Reticulocalbin 3 (RCN3) Antibody |
35620-05111 |
AssayPro |
150 ug |
EUR 261 |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4731.5 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 477.3 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 639 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
for Reticulocalbin 3 (RCN3)ELISA kit |
SEH243Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2575.5 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of for Reticulocalbin 3 (RCN3) in Tissue homogenates, cell lysates and other biological fluids. |
ELISA kit for Reticulocalbin 3 (RCN3) |
4-SEH243Hu |
Cloud-Clone |
-
EUR 4782.00
-
EUR 2526.00
-
EUR 640.00
|
-
10 plates of 96 wells
-
5 plates of 96 wells
-
1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Reticulocalbin 3 (RCN3) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Rcn3 sgRNA CRISPR Lentivector set (Rat) |
K6515801 |
ABM |
3 x 1.0 ug |
EUR 339 |
RCN3 sgRNA CRISPR Lentivector set (Human) |
K1804001 |
ABM |
3 x 1.0 ug |
EUR 339 |
Rcn3 sgRNA CRISPR Lentivector set (Mouse) |
K3917901 |
ABM |
3 x 1.0 ug |
EUR 339 |
Human Reticulocalbin 3 (RCN3)ELISA Kit |
201-12-2941 |
SunredBio |
96 tests |
EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Polyclonal RCN3 Antibody - C-terminal region |
AMM07557G |
Leading Biology |
0.05mg |
EUR 528 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RCN3 - C-terminal region. This antibody is tested and proven to work in the following applications: |
RCN3 Reticulocalbin 3 Human Recombinant Protein |
PROTQ96D15 |
BosterBio |
Regular: 20ug |
EUR 317 |
Description: RCN3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 333 amino acids (21-328 a.a) and having a molecular mass of 37.9kDa.;RCN3 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
Mouse RCN3 (Reticulocalbin-3) ELISA Kit (CUSTOM) |
ELI-14162m |
Lifescience Market |
96 Tests |
EUR 865 |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-10ug |
Novoprotein |
10ug |
EUR 156 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-1mg |
Novoprotein |
1mg |
EUR 2283 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-500ug |
Novoprotein |
500ug |
EUR 1613 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
Recombinant Human Reticulocalbin-3/RCN3 (C-6His) |
CA44-50ug |
Novoprotein |
50ug |
EUR 369 |
Description: Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,1mM DTT,10%Glycerol,pH7.4. |
RCN3 3'UTR Luciferase Stable Cell Line |
TU019704 |
ABM |
1.0 ml |
EUR 1394 |
Rcn3 3'UTR Luciferase Stable Cell Line |
TU117672 |
ABM |
1.0 ml |
Ask for price |
Rcn3 3'UTR GFP Stable Cell Line |
TU167672 |
ABM |
1.0 ml |
Ask for price |
Rcn3 3'UTR Luciferase Stable Cell Line |
TU217432 |
ABM |
1.0 ml |
Ask for price |
Rcn3 3'UTR GFP Stable Cell Line |
TU267432 |
ABM |
1.0 ml |
Ask for price |
RCN3 3'UTR GFP Stable Cell Line |
TU069704 |
ABM |
1.0 ml |
EUR 1394 |
Bovine RCN3 (Reticulocalbin- 3) ELISA Kit (CUSTOM) |
ELI-35646b |
Lifescience Market |
96 Tests |
EUR 928 |
Human RCN3 (Reticulocalbin- 3) ELISA Kit (CUSTOM) |
ELI-41187h |
Lifescience Market |
96 Tests |
EUR 824 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6515802 |
ABM |
1.0 ug DNA |
EUR 154 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6515803 |
ABM |
1.0 ug DNA |
EUR 154 |
Rcn3 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6515804 |
ABM |
1.0 ug DNA |
EUR 154 |
Recombinant Human RCN3 Protein, His, E.coli-1mg |
QP13290-1mg |
EnQuireBio |
1mg |
EUR 2757 |
Recombinant Human RCN3 Protein, His, E.coli-20ug |
QP13290-20ug |
EnQuireBio |
20ug |
EUR 201 |
Recombinant Human RCN3 Protein, His, E.coli-5ug |
QP13290-5ug |
EnQuireBio |
5ug |
EUR 155 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1804002 |
ABM |
1.0 ug DNA |
EUR 154 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1804003 |
ABM |
1.0 ug DNA |
EUR 154 |
RCN3 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1804004 |
ABM |
1.0 ug DNA |
EUR 154 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3917902 |
ABM |
1.0 ug DNA |
EUR 154 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3917903 |
ABM |
1.0 ug DNA |
EUR 154 |
Rcn3 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3917904 |
ABM |
1.0 ug DNA |
EUR 154 |
Human Reticulocalbin 3 (RCN3) Antibody (Biotin Conjugate) |
35620-05121 |
AssayPro |
150 ug |
EUR 369 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (FITC Conjugate) |
35620-05141 |
AssayPro |
150 ug |
EUR 428 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (RPE Conjugate) |
35620-05151 |
AssayPro |
150 ug |
EUR 428 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (APC Conjugate) |
35620-05161 |
AssayPro |
150 ug |
EUR 428 |
Human Reticulocalbin 3 (RCN3) AssayLite Antibody (PerCP Conjugate) |
35620-05171 |
AssayPro |
150 ug |
EUR 471 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K6515805 |
ABM |
3 x 1.0 ug |
EUR 376 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K1804005 |
ABM |
3 x 1.0 ug |
EUR 376 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3917905 |
ABM |
3 x 1.0 ug |
EUR 376 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K6515806 |
ABM |
1.0 ug DNA |
EUR 167 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6515807 |
ABM |
1.0 ug DNA |
EUR 167 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6515808 |
ABM |
1.0 ug DNA |
EUR 167 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K1804006 |
ABM |
1.0 ug DNA |
EUR 167 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K1804007 |
ABM |
1.0 ug DNA |
EUR 167 |
RCN3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K1804008 |
ABM |
1.0 ug DNA |
EUR 167 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3917906 |
ABM |
1.0 ug DNA |
EUR 167 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3917907 |
ABM |
1.0 ug DNA |
EUR 167 |
Rcn3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3917908 |
ABM |
1.0 ug DNA |
EUR 167 |
dCas9-KRAB Lentiviral Vector |
K203 |
ABM |
10 ug |
EUR 228 |
Cas9 Nuclease Lentiviral Vector |
K002 |
ABM |
10 ug |
EUR 154 |
Cas9 Nickase Lentiviral Vector |
K005 |
ABM |
10 ug |
EUR 154 |
pLenti-GFP Lentiviral Control Vector |
LTV-400 |
Cell Biolabs |
100 µL |
EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pSMPUW-MNDnLacZ Lentiviral Control Vector |
LTV-402 |
Cell Biolabs |
10 µg |
EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pSMPUW-Puro Lentiviral Expression Vector |
VPK-212 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-Neo Lentiviral Expression Vector |
VPK-213 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-Hygro Lentiviral Expression Vector |
VPK-214 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
ESR1 Lentiviral Vector (Human) (pLenti-II) |
LV010008 |
ABM |
1.0 ug DNA |
EUR 316 |
pSMPUW-GFP-Puro Lentiviral Control Vector |
LTV-401 |
Cell Biolabs |
10 µg |
EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pLenti-RFP-Puro Lentiviral Control Vector |
LTV-403 |
Cell Biolabs |
100 µL |
EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
pSMPUW-GFP-LC3 Lentiviral Expression Vector |
LTV-801 |
Cell Biolabs |
10 µg |
EUR 1204 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
pSMPUW Universal Lentiviral Expression Vector (Promoterless) |
VPK-211 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Puro Lentiviral Expression Vector |
VPK-215 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Neo Lentiviral Expression Vector |
VPK-216 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Hygro Lentiviral Expression Vector |
VPK-217 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
pSMPUW-IRES-Blasticidin Lentiviral Expression Vector |
VPK-219 |
Cell Biolabs |
10 µg |
EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
OR52B3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739168 |
ABM |
1.0 ug DNA |
Ask for price |
OR52B5P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739169 |
ABM |
1.0 ug DNA |
Ask for price |
OR52B5P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739173 |
ABM |
1.0 ug DNA |
Ask for price |
OR52B5P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739174 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739175 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739179 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739180 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E3P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739181 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739185 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739186 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E7P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739187 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E7P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739191 |
ABM |
1.0 ug DNA |
Ask for price |
OR52E7P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739192 |
ABM |
1.0 ug DNA |
Ask for price |
OR52H2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739193 |
ABM |
1.0 ug DNA |
Ask for price |
OR52H2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739197 |
ABM |
1.0 ug DNA |
Ask for price |
OR52H2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739198 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739199 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739203 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739204 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739205 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739209 |
ABM |
1.0 ug DNA |
Ask for price |
OR52J2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739210 |
ABM |
1.0 ug DNA |
Ask for price |
OR52K3P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739211 |
ABM |
1.0 ug DNA |
Ask for price |
OR52K3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739215 |
ABM |
1.0 ug DNA |
Ask for price |
OR52K3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739216 |
ABM |
1.0 ug DNA |
Ask for price |
OR52L2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739217 |
ABM |
1.0 ug DNA |
Ask for price |
OR52L2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739221 |
ABM |
1.0 ug DNA |
Ask for price |
OR52L2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739222 |
ABM |
1.0 ug DNA |
Ask for price |
OR52M2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739223 |
ABM |
1.0 ug DNA |
Ask for price |
OR52M2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739227 |
ABM |
1.0 ug DNA |
Ask for price |
OR52M2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739228 |
ABM |
1.0 ug DNA |
Ask for price |
OR52N3P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739229 |
ABM |
1.0 ug DNA |
Ask for price |
OR52N3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739233 |
ABM |
1.0 ug DNA |
Ask for price |
OR52N3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739234 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739235 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739239 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739240 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739241 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739245 |
ABM |
1.0 ug DNA |
Ask for price |
OR52P2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739246 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Q1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739247 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Q1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739251 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Q1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739252 |
ABM |
1.0 ug DNA |
Ask for price |
OR52S1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739253 |
ABM |
1.0 ug DNA |
Ask for price |
OR52S1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739257 |
ABM |
1.0 ug DNA |
Ask for price |
OR52S1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739258 |
ABM |
1.0 ug DNA |
Ask for price |
OR52T1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739259 |
ABM |
1.0 ug DNA |
Ask for price |
OR52T1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739263 |
ABM |
1.0 ug DNA |
Ask for price |
OR52T1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739264 |
ABM |
1.0 ug DNA |
Ask for price |
OR52U1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739265 |
ABM |
1.0 ug DNA |
Ask for price |
OR52U1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739269 |
ABM |
1.0 ug DNA |
Ask for price |
OR52U1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739270 |
ABM |
1.0 ug DNA |
Ask for price |
OR52V1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739271 |
ABM |
1.0 ug DNA |
Ask for price |
OR52V1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739275 |
ABM |
1.0 ug DNA |
Ask for price |
OR52V1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739276 |
ABM |
1.0 ug DNA |
Ask for price |
OR52X1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739277 |
ABM |
1.0 ug DNA |
Ask for price |
OR52X1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739281 |
ABM |
1.0 ug DNA |
Ask for price |
OR52X1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739282 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Y1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739283 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Y1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739287 |
ABM |
1.0 ug DNA |
Ask for price |
OR52Y1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739288 |
ABM |
1.0 ug DNA |
Ask for price |
OR55B1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739289 |
ABM |
1.0 ug DNA |
Ask for price |
OR55B1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739293 |
ABM |
1.0 ug DNA |
Ask for price |
OR55B1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739294 |
ABM |
1.0 ug DNA |
Ask for price |
Moreover, the query-by-example downside, and the expressibility and verification downside in ontology-based knowledge entry are launched and investigated.